ESC 365 - Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?

Open Access

Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?

Session: ePosters in chronic heart failure - heart failure with HFrEF (2)

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor F. Bahouth (Nazareth, IL)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Fadel Bahouth

EMMS Nazareth Hospital, Nazareth (Israel)

1 presentation

0 follower

7 more presentations in this session

Association between ultra-short-term heart rate variability and atrial fibrillation in heart failure population

Speaker: Doctor X. Tang (Beijing, CN)

The prognostic value of the CONUT score in predicting long-term mortality in acute decompensated heart failure patients

Speaker: Associate Professor S. Murat (Eskisehir, TR)

Clinical efficacy of heart failure guideline directed medical therapy in patients with titin-truncating variants-associated dilated cardiomyopathy

Speaker: Doctor A. Cerar (Ljubljana, SI)

Qiliqiangxin improves cardiovascular outcomes in patients with heart failure and reduced ejection fraction irrespective of left ventricular ejection fraction

Speaker: Doctor L. Shen (Glasgow, CN)

Role of telemedicine in improving care for heart failure patients

Speaker: Doctor A. Bakhsh (Riyadh, SA)

Access the full session

ePosters in chronic heart failure - heart failure with HFrEF (2)

Speakers: Doctor F. Bahouth, Doctor X. Tang, Associate Professor S. Murat, Doctor A. Cerar, Doctor L. Shen...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources